Literature DB >> 18622427

Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta.

J-M Brondello1, M J Pillaire, C Rodriguez, P-A Gourraud, J Selves, C Cazaux, J Piette.   

Abstract

Cell cycle checkpoints and DNA repair act in concert to ensure DNA integrity during perturbation of normal replication or in response to genotoxic agents. Deficiencies in these protective mechanisms can lead to cellular transformation and ultimately tumorigenesis. Here we focused on Rev3, the catalytic subunit of the low-fidelity DNA repair polymerase zeta. Rev3 is believed to play a role in double-strand break (DSB)-induced DNA repair by homologous recombination. In line with this hypothesis, we show the accumulation of chromatin-bound Rev3 protein in late S-G2 of untreated cells and in response to clastogenic DNA damage as well as an gamma-H2AX accumulation in Rev3-depleted cells. Moreover, serine 995 of Rev3 is in vitro phosphorylated by the DSB-inducible checkpoint kinase, Chk2. Our data also disclose a significant reduction of rev3 gene expression in 74 colon carcinomas when compared to the normal adjacent tissues. This reduced expression is independent of the carcinoma stages, suggesting that the downregulation of rev3 might have occurred early during tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622427     DOI: 10.1038/onc.2008.212

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

Review 1.  Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance.

Authors:  Lauren S Waters; Brenda K Minesinger; Mary Ellen Wiltrout; Sanjay D'Souza; Rachel V Woodruff; Graham C Walker
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

2.  Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress.

Authors:  Ilya N Kotov; Ellen Siebring-van Olst; Philip A Knobel; Ida H van der Meulen-Muileman; Emanuela Felley-Bosco; Victor W van Beusechem; Egbert F Smit; Rolf A Stahel; Thomas M Marti
Journal:  Mol Oncol       Date:  2014-07-22       Impact factor: 6.603

Review 3.  Eukaryotic DNA polymerase ζ.

Authors:  Alena V Makarova; Peter M Burgers
Journal:  DNA Repair (Amst)       Date:  2015-02-19

Review 4.  DNA polymerases and cancer.

Authors:  Sabine S Lange; Kei-ichi Takata; Richard D Wood
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

5.  Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells.

Authors:  Philip A Knobel; Ilya N Kotov; Emanuela Felley-Bosco; Rolf A Stahel; Thomas M Marti
Journal:  Neoplasia       Date:  2011-10       Impact factor: 5.715

6.  Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy.

Authors:  Jason Doles; Trudy G Oliver; Eleanor R Cameron; Gerald Hsu; Tyler Jacks; Graham C Walker; Michael T Hemann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-10       Impact factor: 11.205

7.  DNA polymerase ζ as a potential biomarker of chemoradiation resistance and poor prognosis for cervical cancer.

Authors:  Ting-Yan Shi; Li Yang; Gong Yang; Xiao-Yu Tu; Xiaohua Wu; Xi Cheng; Qingyi Wei
Journal:  Med Oncol       Date:  2013-03-02       Impact factor: 3.064

8.  Translesion synthesis polymerases in the prevention and promotion of carcinogenesis.

Authors:  L Jay Stallons; W Glenn McGregor
Journal:  J Nucleic Acids       Date:  2010-09-22

9.  Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients.

Authors:  M Teresa Agulló-Ortuño; Inmaculada García-Ruiz; C Vanesa Díaz-García; Ana B Enguita; Virginia Pardo-Marqués; Elena Prieto-García; Santiago Ponce; Lara Iglesias; Jon Zugazagoitia; José A López-Martín; Luis Paz-Ares; Juan A Nuñez
Journal:  Cancer Chemother Pharmacol       Date:  2019-12-12       Impact factor: 3.333

Review 10.  Biological and therapeutic relevance of nonreplicative DNA polymerases to cancer.

Authors:  Jason L Parsons; Nils H Nicolay; Ricky A Sharma
Journal:  Antioxid Redox Signal       Date:  2012-09-05       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.